GlaxoSmithKline has selected Jones Lang LaSalle as its single global real estate provider. GSK undertook a full selection process and Jones Lang LaSalle was chosen based on its expertise, capabilities, pricing, and global scope.
Jones Lang LaSalle has been providing global real estate services to GSK for over 10 years, alongside other service providers. Jones Lang LaSalle will be the sole provider of real estate services for GSK portfolio of approximately 80 million square feet across 750 locations. Those services include consulting, transactions, and other professional services as well as the management of vacant and sub-let properties.
Sue Pictor, Director, Global Real Estate, GlaxoSmithKline said: “We are excited to partner with Jones Lang LaSalle to evolve our global real estate strategy and to deliver tangible benefit to GSK. From 2007, Jones Lang LaSalle and Cushman & Wakefield jointly advised GSK. Jones Lang LaSalle put together a competitive bid that identified them as the best fit for GSK moving forward in a single provider model.”
“A twin service provider model has provided a quality transactional service up to this point. However, we believe that the single provider model will allow significant financial benefits through 2012 and beyond. It will also allow us to have a more strategic partnership so that we can evolve our global real estate strategy and to provide high-quality transaction services.”
Tom Bayne-Jardine, Lead Director Corporate Solutions, Jones Lang LaSalle said: “We are delighted to have been selected as the single strategic global real estate adviser by GlaxoSmithKline. Our focus remains to provide the best service and work in partnership with our client’s Global Real Estate team, to deliver new workplace solutions across the globe, including emerging markets in both Asia and Latin America.”
This latest announcement follows recent global appointments for Jones Lang LaSalle Corporate Solutions by Volvo Cars Corporation, UBS, HSBC, Doosan Power Systems and other leading European companies.